These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 554555

  • 41. [The rubella immunity survey of unmarried school-aged women in Taipei and feasibility study of rubella vaccination].
    Wu LC, Yen MH, Ng HT, Yuan FJ.
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Sep; 40(3):309-16. PubMed ID: 3502849
    [No Abstract] [Full Text] [Related]

  • 42. [Vaccination against rubella. A comparison of intranasal and subcutaneous aadministration of the vaccination strain RA 27-3 (author's transl)].
    Petersen EE, Büche M, Doerr HW, Neumann-Haefelin C, Luthardt T, Göttsching C, Haas R.
    Dtsch Med Wochenschr; 1973 Oct 05; 98(40):1842-7. PubMed ID: 4762037
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Current state of the world's experiences with vaccination against rubella].
    Nassi L, Vecchi C.
    Ann Sclavo; 1975 Oct 05; 17(1):17-33. PubMed ID: 1230035
    [Abstract] [Full Text] [Related]

  • 45. [Importance of active and passive anti-rubella immunoprophylaxis].
    Del Piano M.
    Nuovi Ann Ig Microbiol; 1979 Oct 05; 30(6):404-20. PubMed ID: 554136
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Duration of immunity against rubella after post-partum vaccination].
    Hofmann H, Hinterberger K.
    Wien Med Wochenschr; 1974 Mar 16; 124(11):172-4. PubMed ID: 4820575
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Rubella vaccination. An evolving problem for obstetrics and gynecology.
    Monif GR.
    Obstet Gynecol; 1972 Feb 16; 39(2):304-7. PubMed ID: 5057800
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N.
    Hokkaido Igaku Zasshi; 1984 Mar 16; 59(2):180-91. PubMed ID: 6745839
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Physiological parameters of Macaca fascicularis immunized with anti-rubella vaccine with germanium-based adjuvants.
    Karal-Ogly DD, Agrba VZ, Lavrent'eva IN, Ambrosov IV, Matelo SK, Chuguev YP, Gvaramiya IA, Gvozdik TE, Mukhametzyanova EI.
    Bull Exp Biol Med; 2014 May 16; 157(1):81-4. PubMed ID: 24909722
    [Abstract] [Full Text] [Related]

  • 54. Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus.
    Cusi MG, Valensin PE, Cellesi C.
    Arch Virol; 1993 May 16; 129(1-4):337-40. PubMed ID: 8470956
    [Abstract] [Full Text] [Related]

  • 55. Rubella prevention.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1984 Jun 08; 33(22):301-10, 315-8. PubMed ID: 6427574
    [No Abstract] [Full Text] [Related]

  • 56. [Rubella vaccines].
    Leerhoy J, von Magnus H.
    Ugeskr Laeger; 1973 Mar 19; 135(12):637-40. PubMed ID: 4707926
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Susceptibility to rubella and borderline immunity.
    Fogel A, Barnea B, Gerichter CB.
    Isr J Med Sci; 1983 Oct 19; 19(10):934-5. PubMed ID: 6363349
    [Abstract] [Full Text] [Related]

  • 59. [Epidemiologic study on the distribution of rubella antibodies in the female population of the Marches].
    Dini M, Clementi M.
    Minerva Med; 1979 Oct 20; 70(45):3121-3. PubMed ID: 492578
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.